2-Hydroxyglutarate Produced by Neomorphic IDH Mutations Induces PARP Inhibitor Sensitivity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
2-Hydroxyglutarate Produced by Neomorphic IDH Mutations Suppresses Homologous Recombination and Induces PARP Inhibitor Sensitivity
Sci Transl Med 2017 Feb 01;9(375)2463, PL Sulkowski, CD Corso, ND Robinson, SE Scanlon, KR Purshouse, H Bai, Y Liu, RK Sundaram, DC Hegan, NR Fons, GA Breuer, Y Song, K Mishra-Gorur, HM De Feyter, RA de Graaf, YV Surovtseva, M Kachman, S Halene, M Günel, PM Glazer, RS BindraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.